Coming October 1, 2026: FY2027 ICD-10-PCS Procedure changes

FY2027 takes effect on October 1, 2026. Until then FY2026-APR is the current release, and every code page on this site shows FY2026-APR. This list is generated from the official release files: 103 codes added, 16 changed, 39 deleted.

Added codes (103)

• 028F3Z0 Division of Aortic Valve, Percutaneous Approach, Native Leaflet
• 028F3Z1 Division of Aortic Valve, Percutaneous Approach, Prosthetic Leaflet
• 028G3Z0 Division of Mitral Valve, Percutaneous Approach, Native Leaflet
• 028G3Z1 Division of Mitral Valve, Percutaneous Approach, Prosthetic Leaflet
• 0RGA0E0 Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach
• 0RGA0EJ Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach
• 0RGA3E0 Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach
• 0RGA3EJ Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach
• 0RGA4E0 Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach
• 0RGA4EJ Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach
• 0SG00E0 Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach
• 0SG00EJ Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach
• 0SG03E0 Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach
• 0SG03EJ Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach
• 0SG04E0 Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach
• 0SG04EJ Fusion of Lumbar Vertebral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach
• 0SG10E0 Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach
• 0SG10EJ Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach
• 0SG13E0 Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach
• 0SG13EJ Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach
• 0SG14E0 Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach
• 0SG14EJ Fusion of 2 or more Lumbar Vertebral Joints with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach
• 0SG30E0 Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Open Approach
• 0SG30EJ Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Open Approach
• 0SG33E0 Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Approach
• 0SG33EJ Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Approach
• 0SG34E0 Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Anterior Approach, Anterior Column, Percutaneous Endoscopic Approach
• 0SG34EJ Fusion of Lumbosacral Joint with Interbody Fusion Device, Custom-Made Anatomically and Virtually Designed, Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach
• 0W99003 Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Open Approach
• 0W99303 Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Approach
• 0W99403 Drainage of Right Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach
• 0W9B003 Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Open Approach
• 0W9B303 Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Approach
• 0W9B403 Drainage of Left Pleural Cavity with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach
• 0W9C003 Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Open Approach
• 0W9C303 Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Percutaneous Approach
• 0W9C403 Drainage of Mediastinum with Drainage Device, Active Mechanical Clearance, Percutaneous Endoscopic Approach
• 30233S5 Transfusion of High-Dose Immune Globulin into Peripheral Vein, Percutaneous Approach
• 30243S5 Transfusion of High-Dose Immune Globulin into Central Vein, Percutaneous Approach
• 3E00XGF Introduction of Other Enzymatic/Chemical Agent into Skin and Mucous Membranes, External Approach
• 3E01XGF Introduction of Other Enzymatic/Chemical Agent into Subcutaneous Tissue, External Approach
• 5A0527D Assistance with Circulatory Decompression using Impeller Pump, Continuous
• 5A1D701 Performance of Urinary Filtration, Intermittent, Less than 6 Hours Per Day, Selective Cytopheresis
• 5A1D801 Performance of Urinary Filtration, Prolonged Intermittent, 6-18 hours Per Day, Selective Cytopheresis
• 5A1D901 Performance of Urinary Filtration, Continuous, Greater than 18 hours Per Day, Selective Cytopheresis
• B85 Imaging, Eye, Other Imaging
• B85A2ZZ Other Imaging of Right Choroid using Fluorescing Agent
• B85B2ZZ Other Imaging of Left Choroid using Fluorescing Agent
• B85G2ZZ Other Imaging of Right Retinal Vessel using Fluorescing Agent
• B85H2ZZ Other Imaging of Left Retinal Vessel using Fluorescing Agent
• X0HQ05C Insertion of Leadless Neurostimulator Generator into Vagus Nerve, Open Approach, New Technology Group 12
• X27P3NC Dilation of Right Anterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
• X27Q3NC Dilation of Left Anterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
• X27R3NC Dilation of Right Posterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
• X27S3NC Dilation of Left Posterior Tibial Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
• X27T3NC Dilation of Right Peroneal Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
• X27U3NC Dilation of Left Peroneal Artery with Intraluminal Device(s), Small-diameter, Percutaneous Approach, New Technology Group 12
• X28M3DC Division of Ventricular Septum using Transcatheter Septal Scoring Technique, Percutaneous Approach, New Technology Group 12
• X2H43MC Insertion of Temporary Intraluminal Device, Venous Angle Decompression using Impeller Pump into Left Innominate Vein, Percutaneous Approach, New Technology Group 12
• X2RF3LC Replacement of Aortic Valve using Zooplastic Tissue, with Integrated Native Leaflet Clipping Locators, Percutaneous Approach, New Technology Group 12
• X2RG3FC Replacement of Mitral Valve with Balloon-expandable Bioprosthetic Valve with Dock, Percutaneous Approach, New Technology Group 12
• X2RH0GC Replacement of Pulmonary Valve using Size-Adjustable Synthetic Substitute, Open Approach, New Technology Group 12
• X2VJ3HC Restriction of Thoracic Aorta, Ascending and Arch using Branched Intraluminal Device, Integrated System with Innominate Branch, Percutaneous Approach, New Technology Group 12
• X2VW3JC Restriction of Thoracic Aorta, Descending using Branched Intraluminal Device, Integrated System Extension, Percutaneous Approach, New Technology Group 12
• X2VX0KC Restriction of Thoracic Aorta, Arch using Branched Intraluminal Device, with Conical Collar, Open Approach, New Technology Group 12
• XEZ New Technology, Physiological Systems and Anatomical Regions
• XEZ5XKC Computer-Aided Triage and Notification for Imaging Abnormalities in Computed Tomography of Chest, Abdomen and Pelvis, New Technology Group 12
• XEZD3QC Pericardial Cavity Access using Blunt-tip Concealed Needle with Mechanical Gripping Mechanism, Percutaneous Approach, New Technology Group 12
• XEZJ3NC Coronary Artery Access using Image-Guided Crossing and Re-entry System, Percutaneous Approach, New Technology Group 12
• XEZU3HC Computer-Aided Guidance for Intraprocedural Navigation using Ultrasound Imaging with Continuous Needle Tracking in Spinal Canal, Percutaneous Approach, New Technology Group 12
• XEZZXJC High Dimensional Mixture-of-Experts Computer-aided Assessment of Inflammatory Response and Organ Function, for Notification and Triage, New Technology Group 12
• XEZZXLC Computer-Aided Detection and Notification for Imaging Abnormalities in Echocardiography, New Technology Group 12
• XEZZXMC Computer-Aided Detection and Notification for Abnormalities in Electrocardiogram, New Technology Group 12
• XEZZXPC Cardiac Conduction Mechanism, Computer-aided Guidance for Three Dimensional Intraprocedural Navigation using Fluoroscopic Imaging, New Technology Group 12
• XEZZXRC Computer-Aided Detection and Notification of Cardiac Abnormalities using Vital Signs, New Technology Group 12
• XEZZXSC Cardiac Conduction Mechanism, Computer-aided Intraprocedural Visualization for Guidance, New Technology Group 12
• XFJB3CC Inspection of Hepatobiliary Duct using Single-use Choledochoscope, Percutaneous Approach, New Technology Group 12
• XFJB4CC Inspection of Hepatobiliary Duct using Single-use Choledochoscope, Percutaneous Endoscopic Approach, New Technology Group 12
• XFJB8BC Inspection of Hepatobiliary Duct using Single-use Cholangioscope, Via Natural or Artificial Opening Endoscopic Approach, New Technology Group 12
• XFJD3CC Inspection of Pancreatic Duct using Single-use Choledochoscope, Percutaneous Approach, New Technology Group 12
• XFJD4CC Inspection of Pancreatic Duct using Single-use Choledochoscope, Percutaneous Endoscopic Approach, New Technology Group 12
• XFJD8BC Inspection of Pancreatic Duct using Single-use Cholangioscope, Via Natural or Artificial Opening Endoscopic Approach, New Technology Group 12
• XHH80JC Insertion of Contractility Modulation Device with Defibrillator Generator into Chest Subcutaneous Tissue and Fascia, Open Approach, New Technology Group 12
• XRH10NC Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Open Approach, New Technology Group 12
• XRH13NC Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Approach, New Technology Group 12
• XRH14NC Insertion of Carbon/PEEK Spinal Stabilization Device into Cervical Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12
• XRH20NC Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Open Approach, New Technology Group 12
• XRH23NC Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Approach, New Technology Group 12
• XRH24NC Insertion of Carbon/PEEK Spinal Stabilization Device into 2 or more Cervical Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 12
• XRH40NC Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Open Approach, New Technology Group 12
• XRH43NC Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Approach, New Technology Group 12
• XRH44NC Insertion of Carbon/PEEK Spinal Stabilization Device into Cervicothoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12
• XRH60NC Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Open Approach, New Technology Group 12
• XRH63NC Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Approach, New Technology Group 12
• XRH64NC Insertion of Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 12
• XW0134C Introduction of Elamipretide into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 12
• XW0336C Introduction of Landiolol Antiarrhythmic into Peripheral Vein, Percutaneous Approach, New Technology Group 12
• XW0337C Introduction of Zimislecel Allogeneic Stem Cell-Derived Islet Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 12
• XW0436C Introduction of Landiolol Antiarrhythmic into Central Vein, Percutaneous Approach, New Technology Group 12
• XW0Q35C Introduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12
• XW0U0CC Introduction of Recombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold into Joints, Open Approach, New Technology Group 12
• XW0V0BC Introduction of Vancomycin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 12
• XXE2XHC Measurement of Cardiac Conduction Mechanism, Computer-aided Mapping for Planning, New Technology Group 12

Revised codes (16)

• X27535B Dilation of Right Subclavian Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27635B Dilation of Left Subclavian Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27735B Dilation of Right Axillary Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27835B Dilation of Left Axillary Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27935B Dilation of Right Brachial Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27A35B Dilation of Left Brachial Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27B35B Dilation of Right Basilic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27C35B Dilation of Left Basilic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27D35B Dilation of Right Cephalic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X27E35B Dilation of Left Cephalic Vein with Cell Impermeable Intraluminal Device, Percutaneous Approach, New Technology Group 11 (short description revised)
• X9HD01B Insertion of Temporary Infusion Device into Right Inner Ear, Open Approach, New Technology Group 11 (short description revised)
• X9HE01B Insertion of Temporary Infusion Device into Left Inner Ear, Open Approach, New Technology Group 11 (short description revised)
• X9HF01B Insertion of Temporary Infusion Device into Bilateral Inner Ear, Open Approach, New Technology Group 11 (short description revised)
• XW0E33B was: Introduction of DB-OTO via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11
  now: Introduction of Lunsotogene Parvec-cwha via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11
• XW0V0P7 was: Introduction of Antibiotic-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7
  now: Introduction of Gentamicin-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7
• XW143F8 was: Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8
  now: Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8

Deleted codes — valid through September 30, 2026 (39)

• X2KB317 Bypass Right Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7
• X2KC317 Bypass Left Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7
• XD2 New Technology, Gastrointestinal System, Monitoring
• XD2G4V7 Monitoring of Upper GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7
• XD2G8V7 Monitoring of Upper GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7
• XD2H4V7 Monitoring of Lower GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7
• XD2H8V7 Monitoring of Lower GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7
• XRGA0R7 Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
• XRGA3R7 Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
• XRGA4R7 Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
• XRGB0R7 Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
• XRGB3R7 Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
• XRGB4R7 Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
• XRGC0R7 Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
• XRGC3R7 Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
• XRGC4R7 Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
• XRGD0R7 Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
• XRGD3R7 Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
• XRGD4R7 Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
• XW00X27 Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7
• XW01397 Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7
• XW01X27 Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7
• XW023X7 Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
• XW03367 Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
• XW03377 Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7
• XW03387 Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
• XW033B7 Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7
• XW04367 Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7
• XW04377 Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7
• XW04387 Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7
• XW043B7 Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7
• XW0DXR7 Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7
• XW0G7R7 Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7
• XW0H7R7 Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7
• XW133D7 Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
• XW133F8 Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
• XW143D7 Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
• XXE5XR7 Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7
• XXE5XT7 Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7

The new codes get their own pages here on October 1, 2026.